 Tissue polypeptide antigen activity cerebrospinal fluid marker central nervous system metastases breast cancer Tissue antigen TPpA cerebrospinal fluid CSF consecutive breast cancer patients suspected central nervous system CNS patients parenchymal brain metastases carcinomatosis CNS involvement concentration TPpA nonspecific marker cell proliferation patients CNS metastases Mann-Whitney test tentative cutoff value CNS metastases U/L TPpA upper limit values absence CNS metastases U/L cutoff points sensitivity TPpA marker CNS metastases specificity predictive values positive negative tests patients CNS metastases correlation TPpA activity CSF blood samples correlation coefficient Spearman rho patients leptomeningeal carcinomatosis measurements CSF TPpA correlation presence tumor cells CSF neurological clinical function TPpA concentrations parallel clinical response CNS disease progression marker CNS metastases level TPpA CSF breast cancer patients superior level protein lactate dehydrogenase glucose low sensitivity quantitative evaluation treatment leptomeningeal carcinomatosis TPpA level valuable superior CSF cytology tumor cells present CSF samples patients condition